Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
about
Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levelsPerilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondriaTargeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsContribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.TRPC3 contributes to regulation of cardiac contractility and arrhythmogenesis by dynamic interaction with NCX1.Role of the ubiquitin-proteasome system in cardiac dysfunction of adipose triglyceride lipase-deficient micePhysiological Consequences of Compartmentalized Acyl-CoA Metabolism.Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia.Mechanisms of lipotoxicity in the cardiovascular system.Structure, function and metabolism of hepatic and adipose tissue lipid droplets: implications in alcoholic liver disease.Lipid droplets and cellular lipid metabolism.Cardiac oxidative stress in a mouse model of neutral lipid storage disease.Endothelial dysfunction in adipose triglyceride lipase deficiency.Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.Uterine Prx2 restrains decidual differentiation through inhibiting lipolysis in mice.Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysisCritical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.Acyl-CoA Thioesterase 1 (ACOT1) Regulates PPARα to Couple Fatty Acid Flux With Oxidative Capacity During Fasting.
P2860
Q28271295-DC8C7CF4-D9A6-4BCA-A780-A7B33881D923Q28579160-600F817C-2008-4736-B2DD-01EB2E80FA41Q33809886-6AFCB2FA-09CB-4F07-AC4A-86ECD88B07C4Q34418229-5109C234-68C7-4108-9069-86EFE2789095Q34460234-14E771ED-BA54-4399-BFD3-6782E6394498Q34680942-5A42AA9D-DD12-4181-8BE8-89BBE7AD707EQ35953045-007D1AB5-711B-4582-8942-CAA15EB347B9Q36143074-1BA075DC-7F47-4D22-93DF-B9AE6F745A16Q36377252-70B13E65-C92D-42D8-BB96-6A1F62617CD3Q36764000-24EAD1B9-38FA-488E-9E57-676688D02A7AQ37157015-32039CB7-53D5-4E4F-BE80-BC836BB4C4D7Q37226723-0C2A53C8-4253-4C68-8EC7-A5FFA5DB81EBQ37724236-DF14012D-BC89-4182-8ADA-5B1A4DE8D676Q38375945-60451B98-326C-4EA9-885C-3729D3DE3BC5Q39911975-C2149507-067D-4AE6-AD37-F53CBF0867FDQ42003332-DEFCC658-5AFC-47F0-915F-81079635BA7CQ47925533-1875F116-C61A-4D5D-AB81-46109E5A8046Q48290147-B9CF08C8-702F-4501-B6E1-C2E9CE7C2CE3
P2860
Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@ast
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@en
type
label
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@ast
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@en
prefLabel
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@ast
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@en
P2093
P2860
P50
P1476
Cardiac dysfunction in adipose ...... reatment with a PPARα agonist.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2011.01490.X
P407
P577
2012-01-01T00:00:00Z